Cargando…
Envelope Glycoprotein Trimers as HIV-1 Vaccine Immunogens
The HIV-1 envelope glycoprotein spike is the target of neutralizing antibody attack, and hence represents the only relevant viral antigen for antibody-based vaccine design. Various approaches have been attempted to recapitulate Env in membrane-anchored and soluble forms, and these will be discussed...
Autor principal: | Sattentau, Quentin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494206/ https://www.ncbi.nlm.nih.gov/pubmed/26344344 http://dx.doi.org/10.3390/vaccines1040497 |
Ejemplares similares
-
Stabilized HIV-1 envelope glycoprotein trimers for vaccine use
por: Medina-Ramírez, Max, et al.
Publicado: (2017) -
Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunization
por: Turner, Hannah L., et al.
Publicado: (2021) -
Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunization
por: Turner, Hannah L., et al.
Publicado: (2021) -
Improving the immunogenicity of HIV-1 envelope trimer vaccines
por: Sanders, Rogier W
Publicado: (2011) -
Chemical Cross-Linking Stabilizes Native-Like HIV-1 Envelope Glycoprotein Trimer Antigens
por: Schiffner, Torben, et al.
Publicado: (2015)